Acupuncture for radiation-induced xerostomia in patients with cancer: A pilot study

Head and Neck

Volumn 31, Issue 10, 2009, Pages 1360-1368

  Garcia, M Kay ^a   Chiang, Joseph S ^a   Cohen, Lorenzo ^a   Liu, Meide ^a   Palmer, J Lynn ^a   Rosenthal, David I ^a   Wei, Qi ^a   Tung, Samuel ^a   Wang, Congjun ^a   Rahlfs, Thomas ^a   Chambers, Mark S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acupuncture; Dry mouth; Radiationinduced xerostomia; Salivary flow; Xerostomia

Indexed keywords

ACUPUNCTURE; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MOUTH CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION SICKNESS; SQUAMOUS CELL CARCINOMA; XEROSTOMIA;

ACUPUNCTURE THERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TONGUE NEOPLASMS; XEROSTOMIA;

EID: 70349315230     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21110     Document Type: Article

References (59)

1. Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xerostomia in cancer patients. Effect on salivary and serum electrolytes. Cancer 1976;38:273-278.
2. Karlsson G. The relative change in saliva secretion in relation to the exposed area of the salivary glands after radiotherapy of head and neck region. Swed Dent J 1987;11:189-194.
3. Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand 1967;25(Suppl 49):1-126.
4. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
5. Fox PC, Van der Ven PF, Baum BJ, Mandel ID. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1986;61:243-248.
6. Greenspan D, Daniels TE. Effectiveness of pilocarpine in postradiation xerostomia. Cancer 1987;59:1123-1125.
7. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-395. (Pubitemid 23219343)
8. Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 1997;37:571-575.
9. Horiot JC, Lipinski F, Schraub S, et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol 2000;55:233-239. (Pubitemid 30408369)
10. Weiss WW Jr, Brenman HS, Katz P, Bennett JA. Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg 1986;44:845-850. (Pubitemid 16009066)
11. Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow in patients with Sjogren's syndrome. J Dent Res 1988;67:1334-1337.
12. Fontanesi J, Golden EB, Cianci P. Hyperbaric oxygen therapy can reverse radiation-induced xerostomia. J Hyperbaric Med 1991;6:215-221.
13. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-3345. (Pubitemid 30821909)
14. Rudat V, Meyer J, Momm F, et al. Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys 2000;48: 1339-1343. (Pubitemid 30838360)
15. Wasserman T, Mackowiak JI, Brizel DM, et al. Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys 2000;48:1035-1039. (Pubitemid 30802140)
16. Lindegaard JC, Grau C. Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol 2000;57:113-118.
17. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008;118:635-639.
18. Klem ML, Mechalakos JG, Wolden SL, et al. Intensitymodulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2008;70:1100-1107.
19. Shiboski CH, Hodgson TA, Ship JA, Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S66.e1-19.
20. Munter MW, Hoffner S, Hof H, et al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. Int J Radiat Oncol Biol Phys 2007;67:651-659. (Pubitemid 46215873)
21. Buntzel J, Glatzel M, Mucke R, Micke O, Bruns F. Influence of amifostine on late radiation-toxicity in head and neck cancer - a follow-up study. Anticancer Res 2007;27: 1953-1956. (Pubitemid 46954706)
22. Veerasarn V, Phromratanapongse P, Suntornpong N, et al. Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function. J Med Assoc Thai 2006;89:2056-2067. (Pubitemid 44956685)
23. Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer 2002;94: 1151-1156.
24. Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys 2001;50:353-357. (Pubitemid 32472263)
25. Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000;6:15-24. (Pubitemid 30090221)
26. Rydholm M, Strang P. Acupuncture for patients in hospital- based home care suffering from xerostomia. J Palliat Care 1999;15:20-23.
27. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides 1999;33:244-250. (Pubitemid 29398147)
28. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides 1998;32:543-548. (Pubitemid 29010711)
29. Andersen SW, Machin D. Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol 1997;33:146-147. (Pubitemid 127674970)
30. Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar- Mansson B. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol 1996;32B:182-190. (Pubitemid 26180661)
31. Blom M, Dawidson I, Angmar-Mansson B. Acupuncture treatment of xerostomia caused by irradiation of the head and neck region: case reports. J Oral Rehabil 1993; 20:491-494.
32. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. The influence of sensory stimulation (acupuncture) on the release of neuropeptides in the saliva of healthy subjects. Life Sci 1998;63:659-674.
33. Niemtzow RC. Xerostomia technique upgrade: version 25, April 2004. Available at: http//www.n5ev.com.
34. Blom M, Lundeberg T, Dawidson I, Angmar-Mansson B. Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjogren's syndrome. J Oral Rehabil 1993;20:541-548.
35. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181. (Pubitemid 36962641)
36. Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: do patients and their oncologists agree? Br J Cancer 2003;89:1022-1027.
37. Deng L, Gan Y, He S, et al. Chinese acupuncture and moxibustion. Beijing: Foreign Languages Press; 1997.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
39. National Acupuncture Foundation. Clean needle technique manual for acupuncturists. Washington, DC: National Acupuncture Foundation; 1997.
40. Deadman P, Al-Khafaji M, Baker K. A manual of acupuncture. East Sussex, England: Journal of Chinese Medicine Publications; 1999.
41. Huang LC. Auriculotherapy: diagnosis and treatment. Bellaire, TX: Longevity Press; 1996.
42. Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999;16:12-17.
43. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:46-50.
44. Mackowiak J, Scott-Lennox J, Lennox R, et al. Patient benefit questionnaire for xerostomia: development and validation report. Value Health 1999;2:197.
45. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 2001;23:201-213. (Pubitemid 32193215)
46. Lao L. Acupuncture practice, past and present: is it safe and effective? J Soc Integr Oncol 2006;4:13-15.
47. MacPherson H, Thomas K, Walters S, Fitter M. A prospective survey of adverse events and treatment reactions following 34,000 consultations with professional acupuncturists. Acupunct Med 2001;19:93-102. (Pubitemid 34094389)
48. Filshie J. Safety aspects of acupuncture in palliative care. Acupunct Med 2001;19:117-122. (Pubitemid 34094393)
49. Lao L. Safety issues in acupuncture. J Altern Complement Med 1996;2:27-31.
50. Lao L, Hamilton GR, Fu J, Berman BM. Is acupuncture safe? A systematic review of case reports. Altern Ther Health Med 2003;9:72-83. (Pubitemid 36119757)
51. White A. The safety of acupuncture techniques. J Altern Complement Med 2007;13:9-10.
52. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985;110:519-525.
53. Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 1989;119:298-304.
54. Fox PC. Salivary monitoring in oral diseases. Ann NY Acad Sci 1993;694:234-237.
55. Fox PC. Systemic therapy of salivary gland hypofunction. J Dent Res 1987;66:689-692.
56. Screebny L, Banoczy J, Baum BJ, et al. Saliva: its role in health and disease. Working Group of the Commission on Oral Health, Research and Epidemiology. Int Dent J 1992;42(4, Suppl 2):287-304.
57. Fox PC, Eversole LR. Diseases of the salivary glands. In: Silverman S, Eversole LR, Truelove EL, editors. Essentials of oral medicine. Ontario: BC Decker; 2002. pp 260-276.
58. Dreizen S, Daly TE, Drane JB, Brown LR. Oral complications of cancer radiotherapy. Postgrad Med 1977;61: 85-92.
59. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704. (Pubitemid 32515326)